DEV PATEL et al. Role of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor Therapy in treatment of Patients with Polycystic Ovary Syndrome: A systemic Review of Metabolic and Cardiovascular Outcomes . Journal For International Medical Graduates, [S. l.], v. 3, n. 1, 2024. DOI: 10.56570/jimgs.v1i1.149. Disponível em: https://www.jimgs.com/ojs/index.php/journal/article/view/149. Acesso em: 18 jan. 2026.